Application 077750
- Type
- ANDA
- Sponsor
- IVAX SUB TEVA PHARMS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CABERGOLINE | CABERGOLINE | TABLET;ORAL | 0.5MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0093-5420 | Cabergoline | Cabergoline | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5420 | Cabergoline | Cabergoline | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5420 | Cabergoline | Cabergoline | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5420 | Cabergoline | Cabergoline | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5420 | Cabergoline | Cabergoline | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-3157 | Cabergoline | Cabergoline | A-S Medication Solutions | ANDA | Current |
| 50090-3157 | Cabergoline | Cabergoline | A-S Medication Solutions | ANDA | Current |
| 50090-3157 | Cabergoline | Cabergoline | A-S Medication Solutions | ANDA | Current |